← All trials
NCT04847921
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2021
- Primary completion
- Apr 29, 2024
- Completion date
- Apr 29, 2024
- First posted
- Apr 19, 2021
- Last posted
- May 6, 2021
- Enrollment
- 60
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Colorado, DenverLead sponsor
- University of Colorado, DenverOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.